1691 - 1700 of 8093 Results
Title
Year
-
OPENTitle: Parkinson’s Disease Severity Estimation using Deep Learning and Cloud TechnologyJournal Name: 2022 IEEE International Conference on Omni-layer Intelligent Systems (COINS)Publisher: IEEEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/coins54846.2022.9854945Best OA location URL: https://zenodo.org/record/7020693/files/PD-Severity.pdfCitation Count: 0
-
OPENTitle: Peripheral tau as a biomarker for neurodegenerative diseases: is life on Earth, life on Mars?Journal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 8Start Page: 2629End Page: 2631Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awac281Best OA location URL: https://academic.oup.com/brain/article-pdf/145/8/2629/45599741/awac281.pdfCitation Count: 0
- PLA2G6-associated neurodegeneration in four different populations-case series and literature review2022RESTRICTEDTitle: PLA2G6-associated neurodegeneration in four different populations-case series and literature reviewJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 66End Page: 74Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.016Best OA location URL: http://manuscript.elsevier.com/S1353802022002115/pdf/S1353802022002115.pdfCitation Count: 4
- Reply to: “Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations”?2022RESTRICTEDTitle: Reply to: “Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations”?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1782End Page: 1782Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29136Citation Count: 0
- Reply to: “Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1‐Associated Parkinson's Disease”2022OPENTitle: Reply to: “Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1‐Associated Parkinson's Disease”Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1781End Page: 1782Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29131Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756875Citation Count: 0
-